Entity Common Stock, Shares Outstanding of NRX Pharmaceuticals, Inc. from 21 Mar 2018 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NRX Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 21 Mar 2018 to 13 Nov 2025.
  • NRX Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 28,097,627, a 132% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NRX Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 28,097,627 +16,003,533 +132% 13 Nov 2025 10-Q 14 Nov 2025 2024 Q3
Q2 2025 19,705,077 +8,810,384 +81% 14 Aug 2025 10-Q 18 Aug 2025 2024 Q2
Q1 2025 16,915,647 -78,784,133 -82% 14 Mar 2025 10-K 14 Mar 2025 2024 FY
Q3 2024 12,094,094 -71,825,460 -86% 14 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 10,894,693 -59,414,962 -85% 14 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 95,699,780 +24,142,200 +34% 25 Mar 2024 10-K 29 Mar 2024 2023 FY
Q3 2023 83,919,554 +16,278,240 +24% 13 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 70,309,655 +2,668,341 +3.9% 26 May 2023 10-K/A 26 May 2023 2022 FY
Q1 2023 71,557,580 +4,916,266 +7.4% 29 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 67,641,314 +8,830,976 +15% 13 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 67,641,314 +64,953,072 +2416% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 66,641,314 +63,953,072 +2379% 24 Mar 2022 10-K/A 29 Apr 2022 2021 FY
Q3 2021 58,810,338 12 Nov 2021 10-Q/A 12 Aug 2022 2021 Q3
Q2 2021 2,688,242 0 0% 17 May 2021 10-Q 21 May 2021 2021 Q1
Q1 2021 2,688,242 -27,786 -1% 30 Mar 2021 10-K 01 Apr 2021 2020 FY
Q4 2020 2,688,242 -27,786 -1% 16 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 2,688,242 -4,227,486 -61% 12 Aug 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 2,716,028 -6,319,472 -70% 05 May 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 2,716,028 31 Dec 2019 10-K 30 Mar 2020 2019 FY
Q3 2019 6,068,840 -2,966,660 -33% 08 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 6,915,728 -2,119,772 -23% 08 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 9,035,500 0 0% 14 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 9,035,500 07 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 9,035,500 03 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 9,035,500 21 Mar 2018 10-K 23 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.